Received date: July 24, 2018; Accepted date: September 24, 2018; Published date: September 30, 2018
Citation: Lupande DM, Busa GM, Pululu C, Mukuku O, Phoba MF, et al. (2018) Risk Factors of the Transmission of the HIV, Hepatitis B and C and Syphilis among Blood Donors at the Saint Luc General Hospital of Kisantu, Democratic Republic of Congo. J HIV Retrovirus Vol. 4 No.3:18
Introduction The blood donation is an altruistic but dangerous act. The Human Immunodeficiency Virus (HIV), the Hepatitis B Virus (HBV), the Hepatitis C Virus (HCV) and Syphilis must be subjected to a regular epidemiological monitoring in order to reduce the infectious risk of their transmission. This study aims to determine the epidemiological and serological profile of blood donors of to the Saint Luc General Hospital of KISANTU. Methods This retrospective study from November 2010 to November 2014 conducted among blood donors at the Saint Luc Hospital in KISANTU. For the screening, only the rapid tests were used (Determine HIV 1 and 2, Determine HBsAg, HCV One Step and RPR). Statistical analysis was performed using SPSS 21.0, the chi-square test or Fisher exact test (when recommended) was used to find a relationship between epidemiological parameters and seropositivity to tested antigens. The significance level was set at p <0.05. Results A total of 7434 blood donors were collected including 6787 male (91.30%) and 647 female (8.70%). The majority of donors were between 26-35 years of age (39.52%); the mean age was 31.1 ± 9.1 years. The age group of 36-45 years was a protective factor for HBV (OR <1, p <0.05), seroprevalence of HIV, HCV and syphilis were 2.93%, 1.86% and 0.66%. Conclusions A high prevalence of Hbs antigen has been found in our series. Epidemiological surveillance must be strengthened within the national blood transfusion program in DR Congo in order to reduce the infectious risks that are transmitted during blood transfusions.
Transfusion; Hepatitis B and C; Kisantu; Blood donors; Syphilis
Blood transfusion is a medical and beneficial practice by solving lives for those who are in need, which correct an hematological failure induced by the lack of blood product; but this treatment is likely to be responsible for the transmission of certain infectious agents, such as Human Immunodeficiency Virus (HIV), hepatitis B and C, and Treponema palludum (syphilis). These transmissible infectious agents are among the greatest threats to blood safety in recipients [1,2].
Blood transfusion accounts for 5% to 10% of the transmission of HIV infection in sub-Saharan Africa . According to the World Health Organization, in 2016, 37 million people were living with HIV worldwide, of which 70% or 25 million people live in resource-poor countries .
Hepatitis B and C viruses infect 350 and 170 million people around the world, respectively. These viruses are a public health problem because they are responsible for the majority of liver cancers in the world. More than 80% of those infected with the hepatitis C virus are chronic carriers of the virus and a potential reservoir for transmission .
For the hepatitis B virus, the geographical distribution of prevalence among blood donors in Congo is not different from that of other african countries, as demonstrated by numerous studies. This condition is a public health problem, since the prevalence of chronic carriage of HBs antigen varies between 8% and 15% in the general population, and is 5.8% among blood donors in Kinshasa; for the hepatitis C virus, its prevalence among blood donors in Kinshasa is 4.8% and 2.68% in Brazzaville, an neighboring city of Kisantu; in the Republic of Congo [6,7].
Syphilis is also a systemic disease caused by Treponema pallidum that can be transmitted through sexual contact, blood transfusion and vertical transmission. In sub-Saharan Africa, syphilis remains a serious public health problem. The prevalence of active syphilis among African countries was 12.8% in Tanzania and 3.8% in Kenya. In Democratic Republic of the Congo, the prevalence of syphilis among blood donors in Kisangani was 1.4% in 2014 [2,8].
Unlike the hepatitis B virus, no effective vaccine is available against the hepatitis C virus and the treatment offered to the patient with hepatitis C is expensive, however, the infection can now be permanently cured in more 99% of patients who achieve a sustained virological response with marketing authorization for Direct-Acting Antivirals (DAA) .
Advances in screening for HIV, Hepatitis B and C, and Syphilis have significantly reduced the risk of contamination when donating blood; in sub-Saharan Africa, two factors account for difficulties in achieving optimal blood transfusion safety, the relatively high prevalence of blood-borne infections in the population, and the still insufficient proportion of voluntary blood donors who are the safest group .
In developed countries, this infectious risk is almost zero because they have robust diagnostic and infrastructure equipment for an efficient laboratory screening, which is still a big challenge in many african countries, including the DRC. The purpose of this study is to document the seroprevalence of HIV infection, hepatitis B and C, and syphilis among volunteer blood donors at Saint Luc General Hospital of KISANTU (HSLK), 120 km away, South of Kinshasa.
This is a retrospective study based on the data recorded in the laboratory that took place over a period from November 2010 to November 2014. Included in our study were all blood donors registered at the HSLK Blood Bank during the study period. Age and sex the blood group of each subject included; serological results from HIV, Hepatitis B and C and Syphilis tests were sought. All data were collected and processed anonymously after authorization was obtained from the HSLK authorities. The study being retrospective and documentary, the opinion of the ethics committee was not necessary and the principles of Helsinki had been respected.
The detection of infectious markers has been carried out according to the recommendations of the national blood transfusion program and the national program against AIDS and STIs, which advocate the use of the following rapid tests: The presence of HIV1 and HIV2 antibodies has been searched with a quick test (Alere Medical CO. ltd). Hepatitis B surface antigen (Ag Hbs) was tested using HBsAg One Step Hepatitis B Surface Antigen Test Divice (serum/plasma) rapid test. Anti- Hepatitis C Virus antibodies were investigated with HCV one step Hepatitis C Virus Test Strip (serum/plasma). Rapid Plasma Reagin carbon is the test used for the diagnosis of Treponema pallidum infection. The Simonin-Machon and Beth-Vincent methods were used for ABO blood grouping performed on slides using red cells and monoclonal antisera (Anti-A, Anti-B, Anti-AB and Anti-D). The data was analyzed using Excel 2010 and SPSS 21.0 software. The mean and standard deviation were calculated and the chi-square or Fischer Exact test to find the association between sociodemographic parameters and the seropositivity of the antigens and/or antibodies sought. The p <0.05 was set at significance level.
During the study period, 7434 blood donors registered at the HSLK blood bank were collected. Of the 7434 blood donors that were collected, 6787 (91.30%) were male, 647 (8.70%) were female. With respect to age, 2400 (32.28%) were between the ages of 18-25, 2938 (39.52%) were between the ages of 26-35, and 1524 (20.5%) were between 36-45 years, and 572 (7.69%) were older than 45 years. With regard to the blood group, 3812 (51.28%) are of blood type O, 1845 (24.82%) are of blood group A, 1476 (19.85%) are of blood group B, and 301 (4.05%) are of AB blood group.
For the seroprevalence rate, it was high for HBV with a population of 354 (4.76%), followed by HIV and HCV with a population of 218 (2.93%) for HIV, 138 (1.86%) for HCV. Seroprevalence rate of syphilis was lower with 49 (0.66%).
HIV, HBV, HCV and Syphilis infections are the major communicable infections considered to be public health problems in the lowincome country. Those four mains infections are transmitted parentally; blood transmission is therefore, a potential route of transmission .
In this study, 7434 blood donors were identified with a majority of male donors (91.30%) (Table 1). These results are similar to those found by other authors who incriminate certain beliefs or ancestral african beliefs, for whom; in comparison with women, men are more likely to be in better health, according to these same authors the physiological constraints in women such as the menstrual cycle and certain obstetric factors, especially pregnancy, are restrictive parameters for the woman to do a blood donation [1,10]. And everything suggests that the donors in our study are a reflection of these claims.
|Average ± ET||31.1 ± 9.1|
ET: standard deviation
Table 1: Sociodemographic data of volunteer donors of Kisantu blood bank.
Our series reports seroprevalence of 2.93% for HIV, 4.7% for Hbs Antigen, 1.86 for hepatitis C and 0.66% for syphilis (Table 2).
|Markers||Manpower (n)||Percentage||IC 95%|
HIV: Human Immunodeficiency Virus; HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; RPR: Rapid Plasma Reagin
Table 2: Seropositivity to HIV, hepatitis B and C Virus, and syphilis among blood donors (N = 7434).
The seroprevalence for HIV encountered in our study is higher compared to that found at the University Clinics of Lubumbashi by Christian and Olivier , and in the study of X. Dray in Djibouti .
However, it is weaker than that obtained by Batina in Kisangani , and that obtained by S. Mole in Cameroon . Donors aged between 26-35 years old have a high prevalence, while those between 36-45 years of age have a low prevalence. Other authors have made the same observation as we . This can be explained by the fact that the young population in general, precisely whose age varies between 20 and 35 years old, largely ignores how HIV is transmitted and how to protect themselves from it, the level of education being a sub-basement not negligible. The lack of sufficient information about HIV/AIDS in our environment could explain this ignorance.
Different seroprevalence rates of HBV infection are reported among blood donors in Africa. The highest rates were found in some countries, such as Nigeria (18.6%), Guinea Bissau (16.2%) and Burkina Faso (14.96%) .
The seroprevalence of HBV infection observed in our study is high compared to that observed by Malam Abdou in Niger  and that obtained by Rakotoniama in Antananarivo in Madagascar . However, it is weaker than that obtained by Batina in Kisangani  and those obtained by O. Kra in Côte d'Ivoire  and Mbendi in Kinshasa . The 36-45 age group is the least affected compared to the others, making it a protective factor (OR <1) with a statistically significant relationship (p<0.0001) (Table 3). Variations in the incidence of hepatitis B are thought to be related to poorly known hepatitis transmission patterns and cultural traditions including tattooing, multiple sexual partners, and educational attainment.
|Age (years)||n (%)||OR (IC95%)||n (%)||OR (IC95%)||n (%)||OR (IC95%)||n (%)||OR (IC95%)|
|18-25||14 (0.58)||0.47 (0.19-1.18)||111 (4.63)||1.03 (0.76-1.41)||45 (1.88)||0.97 (0.50-1.89)||68 (2.83)||0.95 (0.55-1.63)|
|26-35||21 (0.71)||0.58 (0.24-1.37)||149 (5.07)||1.14 (0.85-1.53)||42 (1.43)||0.74 (0.38-1.44)||93 (3.17)||1.07 (0.63-1.80)|
|36-45||7 (0.46)||0.37 (0.13-1.07)||68 (4.46)||0.13 (0.07-0.22)*||40 (2.62)||1.37 (0.70-2.69)||40 (2.62)||0.88 (0.49-1.56)|
|>45||7 (1.22)||1||26 (4.55)||1||11 (1.92)||1||17 (2.97)||1|
|Female||8 (1.24)||2.06 (0.96-4.41)||27 (4.17)||0.86 (0.57-1.28)||13 (2.01)||1.09 (0.61-1.94)||23 (3.55)||1.25 (0.80-1.93)|
|Male||41 (0.60)||1||327 (4.82)||1||125 (1.84)||1||195 (2.87)||1|
*P<0.0001, RPR: Rapid Plasma Reagin; HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; HIV: Human Immunodeficiency Virus
Table 3: Association between socio-demographic characteristics of blood donors and seropositivity to Treponema pallidum, HIV, hepatitis B and C.
The seroprevalence of HCV infection is 1.86%. This is higher than that found by Malese in Ethiopia  and that obtained by Malam Abdou in Niger, but less important than that obtained by Baleka in Kinshasa , and that obtained by Kabinda and all. At the eastern part of DRC . This proves a very high prevalence of hepatitis C virus in the DRC compared to other african countries including Ethiopia and Niger. And this high rate is explained by the fact that the majority of the Congolese population is unaware of the mode of transmission of the hepatitis C virus, the late introduction of the HCV test and the various means to prevent it.
The seroprevalence for syphilis obtained during our study is 0.66%, which is higher than that reported by Christian in Lubumbashi , but much lower than that encountered by Osinga in Kisangani  and Baidy in Mauritania . The ignorance of the population about syphilis and its different modes of transmission could explain this high rate.
This study has some limitations, including the use of rapid diagnostic tests in the diagnosis of these different post-transfusion infections. Parameters such as the number of blood donations per donor and the categorization of volunteer blood donors as first-time donors and regular or family donors were not taken into account, as the data were retrospective.
This study confirms that infections transmitted by blood transfusion are a public health problem and show a very high prevalence of hepatitis B and HIV and a low tendency for hepatitis C and syphilis. It shows a high prevalence of these different infectious markers in young subjects. For hepatitis B, the age group of 36-45 years was a protective factor; no risk factors were found for the other infectious markers. In addition, this study showed a marked increase in male donors as opposed to female donors. In addition, donors of blood group O were in the majority.
These data were valued in the form of a Poster at the 2nd ICART Symposium (International Center for Advanced Research and Training), held in Bukavu in the Democratic Republic of Congo, from 19 to 21 August 2017.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : November 20, 2018